Oncology Central

Waldenström macroglobulinemia at 70


Over the last seven decades, Waldenström macroglobulinemia (WM) has changed from a clinical observation by an astute clinician to an uncommon, but well-defined clinical–pathologic entity. Similarly, therapeutic advances have evolved and now parallel our increasing understanding of the biology of WM.

To view restricted content, please:



News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.